Exelixis | Zapasy



Stock Zmiana Data
Acadia Pharmaceuticals USD 21.95M 39.09M 2024-12
Agios Pharmaceuticals USD 27.62M 1.19M 2024-12
Amgen USD 7B 364M 2024-12
AstraZeneca USD 5.29B 374M 2024-12
Bayer EUR 13.4B 458M 2024-12
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Bristol-Myers Squibb USD 2.56B 775M 2024-12
Cytokinetics 0 0 2023-12
Eisai JPY 206.11B 14.02B 2024-12
Eli Lilly USD 7.59B 129.4M 2024-12
Exelixis USD 22.39M 1.38M 2024-12
Genmab DKK 62M 9M 2024-12
Glaxosmithkline 5.92B 216M 2024-09
Incyte USD 58.87M 11.57M 2024-12
Ionis Pharmaceuticals USD 12.51M 15.94M 2024-12
MacroGenics USD 3.24M 2.13M 2024-09
Merck USD 6.11B 135M 2024-12
Moderna USD 117M 295M 2024-12
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Novartis USD 5.72B 216M 2024-12
Pfizer USD 10.85B 870M 2024-12
Sanofi 10.61B 943M 2024-06
Takeda JPY 1.25T 40B 2024-12
Ultragenyx Pharmaceutical USD 45.01M 1.67M 2024-12
Xencor USD 0 0 2020-06



Exelixis Zapasy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.